Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low-Level Viraemia.

Saved in:
Bibliographic Details
Title: Increased Risk for Liver Disease in Patients With Chronic Hepatitis B Virus Infection and Low-Level Viraemia.
Authors: Kwo PY; Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California, USA., Telep LE; Gilead Sciences, Inc., Foster City, California, USA., Hong LS; Gilead Sciences, Inc., Foster City, California, USA.; Redsen Limited, Tring, UK., Chuo CY; Gilead Sciences, Inc., Foster City, California, USA., Chiang B; Gilead Sciences, Inc., Foster City, California, USA., Naik SD; Gilead Sciences, Inc., Foster City, California, USA., Frenette CT; Gilead Sciences, Inc., Foster City, California, USA., Singer AW; Gilead Sciences, Inc., Foster City, California, USA., Chokkalingam AP; Gilead Sciences, Inc., Foster City, California, USA., Wong RJ; Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California, USA., Yee LJ; Gilead Sciences, Inc., Foster City, California, USA., Graham CS; Division of Infectious Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jun; Vol. 63 (12), pp. 1626-1634. Date of Electronic Publication: 2026 Apr 01.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70613